Last update 01 Nov 2024

PDE3A x ENT

Basic Info

Related Targets
PDE3AENT

Related

1
Drugs associated with PDE3A x ENT
Y-5
Target
ENT x PDE3A
Mechanism
ENT inhibitors [+1]
Active Org.
Nanjing Ningdan New Drug Technology Co., Ltd.Nanjing Ningdan New Drug Technology Co., Ltd.
Originator Org.
Nanjing Ningdan New Drug Technology Co., Ltd.Nanjing Ningdan New Drug Technology Co., Ltd.
Active Indication
Stroke
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with PDE3A x ENT
Login to view more data
100 Translational Medicine associated with PDE3A x ENT
Login to view more data
0 Patents (Medical) associated with PDE3A x ENT
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free